Trial intelligence / Profile preview

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials

NCT04580368Recruiting

Sponsor
Cincinnati Children's Hospital Medical Center
Start
May 2021
Primary completion
Dec 2028
Countries
1
01

Overview

Open-label, single-arm trial in cystic fibrosis (CF), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoint: Percent Predicted Forced Expiratory Volume in 1 second at 16 weeks. Started May 2021; status: recruiting.

02

Conditions

cystic fibrosis (CF)

Beyond the preview

Go deeper on NCT04580368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04580368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call